Funds holding Contineum Therapeutics Inc
ISIN US21217B1008 · United States
- Fund holders
- 44
- Of which ETFs
- 11 33 other funds
- Value held
- 46.9M $
- Share of capital
- 15.0 % of 23.1M shares on Oct 27, 2025
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 910,659 | 11.9M $ | 0.00 % | 3.94 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 676,121 | 8.7M $ | 0.84 % | 2.93 % | as of Apr 30, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 450,000 | 6.9M $ | 0.11 % | 1.95 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 280,000 | 3.6M $ | 0.12 % | 1.21 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 272,884 | 3.6M $ | 0.00 % | 1.18 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 200,362 | 2.6M $ | 0.03 % | 0.87 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 97,898 | 1.5M $ | 0.00 % | 0.42 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 92,303 | 1.4M $ | 0.01 % | 0.40 % | as of Feb 28, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 80,000 | 1M $ | 0.10 % | 0.35 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 61,670 | 805.4K $ | 0.07 % | 0.27 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 39,102 | 501.3K $ | 0.00 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 33,762 | 517.9K $ | 0.00 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 26,900 | 351.3K $ | 0.29 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 26,733 | 410.1K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 26,179 | 401.6K $ | 0.02 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 22,380 | 292.3K $ | 0.34 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 17,542 | 269.1K $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 16,648 | 217.4K $ | 0.00 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 15,969 | 204.7K $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 14,836 | 190.2K $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 13,802 | 180.3K $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 12,540 | 160.8K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 12,354 | 158.4K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 11,300 | 147.6K $ | 0.01 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 10,500 | 161.1K $ | 0.00 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 8,450 | 108.3K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 4,969 | 63.7K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 4,445 | 57K $ | 0.00 % | 0.02 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 4,355 | 56.9K $ | 0.03 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 3,900 | 50.9K $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Index Fund Fidelity Salem Street Trust | 3,666 | 47K $ | 0.01 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 3,412 | 44.6K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 3,293 | 42.2K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 2,874 | 37.5K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 2,401 | 36.8K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 1,762 | 22.6K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 1,753 | 26.9K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| U.S. CORE EQUITY 1 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,498 | 19.2K $ | 0.01 % | as of Apr 30, 2026 ↗ | |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 1,453 | 19K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 1,293 | 19.8K $ | 0.03 % | 0.01 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 1,067 | 16.4K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 854 | 10.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 433 | 5.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 161 | 2.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.84 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.34 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.29 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 0.12 % | as of Apr 30, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 0.11 % | as of Feb 28, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 0.10 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.07 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity Fund American Century ETF Trust | 0.03 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 44 | +13 | 3,474,483 | +9.1 % |
| 2026Q1 | 31 | +7 | 3,185,349 | +29.9 % |
| 2025Q4 | 24 | -6 | 2,451,847 | +3.6 % |
| 2025Q3 | 30 | -53 | 2,367,210 | -18.7 % |
| 2025Q2 | 83 | -3 | 2,912,800 | +11.7 % |
| 2025Q1 | 86 | +3 | 2,607,339 | +22.2 % |
| 2024Q4 | 83 | +51 | 2,133,068 | +75.8 % |
| 2024Q3 | 32 | +30 | 1,213,217 | +151.8 % |
| 2024Q2 | 2 | 481,767 |
Institutional managers
86 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,841,334 | 37.1M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,734,836 | 35.6M $ | as of Mar 31, 2026 |
| JOHNSON & JOHNSON | 1,979,173 | 25.8M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,839,227 | 24M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 1,685,635 | 22M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,535,449 | 20.1M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 1,420,838 | 18.6M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 1,296,012 | 16.9M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,255,592 | 16.4M $ | as of Mar 31, 2026 |
| FMR LLC | 814,871 | 10.6M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 807,874 | 10.6M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 800,198 | 10.5M $ | as of Mar 31, 2026 |
| Longaeva Partners L.P. | 732,088 | 9.6M $ | as of Mar 31, 2026 |
| SECTORAL ASSET MANAGEMENT INC | 727,587 | 9.5M $ | as of Mar 31, 2026 |
| HHLR ADVISORS, LTD. | 669,337 | 8.7M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 669,123 | 8.7M $ | as of Mar 31, 2026 |
| RED TREE MANAGEMENT, LLC | 638,158 | 8.3M $ | as of Mar 31, 2026 |
| Versant Venture Management, LLC | 542,628 | 7.1M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 513,053 | 6.7M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 494,000 | 6.5M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 371,636 | 4.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 350,200 | 4.6M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 307,108 | 4M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 301,729 | 3.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 282,038 | 3.7M $ | as of Mar 31, 2026 |
Declared shareholders of Contineum Therapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Balyasny Asset Management L.P. and 4 others | 7.40 % | 2,417,723 | as of Mar 31, 2026 · SCHEDULE 13G |
| Millennium Management LLC and 2 others | 5.10 % | 1,658,349 | as of Apr 13, 2026 · SCHEDULE 13G |
| RA Capital Management, L.P. and 3 others | 4.00 % | 1,296,012 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Contineum Therapeutics Inc". https://titelia.com/en/stocks/contineum-therapeutics-inc-US21217B1008